Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.33 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.33 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fumaric Acid SCHEMBL7974945 | 0.81 | TSHR (0.47) | MEN1KMT2AMAPTCACNA1BAPBA1 | |
| Maleic Acid SCHEMBL460391 | 0.81 | TSHR (0.47) | MEN1KMT2AMAPTCACNA1BAPBA1 | |
| Acrylic Acid SCHEMBL16468074 | 0.79 | LMNA (0.50) | MEN1KMT2AHCAR2 | |
| SCHEMBL7125436 | 0.79 | ALDH1A1 (0.45) | MAPTCACNA1BAPBA1 | |
| SCHEMBL996827 | 0.78 | — | — | |
| SCHEMBL10423 | 0.78 | — | — | |
| SCHEMBL8799194 | 0.78 | — | — | |
| SCHEMBL17912275 | 0.78 | TSHR (0.47) | MEN1KMT2AHCAR2 | |
| SCHEMBL11460249 | 0.76 | — | — | |
| Ammonia Solution, Strong SCHEMBL28313820 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3335738-B1 | NEW TYPE CYANOACRYLATE MEDICAL ADHESIVE AND PREPARATION METHOD AND USE THEREOF | SHEN WEI (CN) | 2019-11-06 | — | — | EP | claimed |
| US-7932305-B2 | Viscous α-cyanoacrylate compositions | ETHICON, INC. (US) | 2011-04-26 | — | — | US | claimed |
| US-20090326095-A1 | Viscous alpha-Cyanoacrylate Compositions | ETHICON, INC. | 2009-12-31 | — | — | US | claimed |
| WO-2009158302-A2 | VISCOUS ALPHA-CYANOACRYLATE COMPOSITIONS | CLOSURE MEDICAL CORPORATION (US) | 2009-12-30 | — | — | WO | claimed |
| EP-1317294-B1 | ABSORBABLE ADHESIVE COMPOSITIONS | CLOSURE MEDICAL CORP (US) | 2005-03-16 | — | — | EP | claimed |
| EP-1317294-A1 | ABSORBABLE ADHESIVE COMPOSITIONS | Closure Medical Corporation (US) | 2003-06-11 | — | — | EP | claimed |
| US-20020037310-A1 | Absorbable adhesive compositions | CLOSURE MEDICAL CORPORATION (US) | 2002-03-28 | — | — | US | claimed |
| WO-2002009785-A1 | ABSORBABLE ADHESIVE COMPOSITIONS | CLOSURE MEDICAL CORPORATION (US) | 2002-02-07 | — | — | WO | claimed |
| EP-3335738-B1 | NEW TYPE CYANOACRYLATE MEDICAL ADHESIVE AND PREPARATION METHOD AND USE THEREOF | SHEN WEI (CN) | 2019-11-06 | — | — | EP | disclosed |
| EP-2089308-B1 | DISPENSER | ETHICON INC (US) | 2018-12-26 | — | — | EP | disclosed |
| US-9642658-B2 | Device and method for delivery of therapeutic agents via internal implants | ORTHOCLIP LLC (US) | 2017-05-09 | — | — | US | disclosed |
| EP-2629687-A1 | DEVICE AND METHOD FOR DELIVERY OF THERAPEUTIC AGENTS VIA INTERNAL IMPLANTS | Bioshape Solutions Inc. (US) | 2013-08-28 | — | — | EP | disclosed |
| CN-101600643-B | Dispenser | CLOSURE MEDICAL CORP | 2013-07-31 | — | — | CN | disclosed |
| US-8287202-B2 | Method for dispensing a polymerizable monomer adhesive | ETHICON, INC. (US) | 2012-10-16 | — | — | US | disclosed |
| EP-1317294-A1 | ABSORBABLE ADHESIVE COMPOSITIONS | Closure Medical Corporation (US) | 2003-06-11 | — | — | EP | disclosed |
| US-6547467-B2 | Microapplicators, delivery systems and methods for adhesives and sealants | CLOSURE MEDICAL CORPORATION | 2003-04-15 | — | — | US | disclosed |
| WO-2003020358-A1 | MICROAPPLICATORS, DELIVERY SYSTEMS AND METHODS FOR ADHESIVES AND SEALANTS | CLOSURE MEDICAL CORPORATION (US) | 2003-03-13 | — | — | WO | disclosed |
| US-20030044219-A1 | MICROAPPLICATORS, DELIVERY SYSTEMS AND METHODS FOR ADHESIVES AND SEALANTS | CLOSURE MEDICAL CORPORATION (US) | 2003-03-06 | — | — | US | disclosed |
| US-20020037310-A1 | Absorbable adhesive compositions | CLOSURE MEDICAL CORPORATION (US) | 2002-03-28 | — | — | US | disclosed |
| WO-2002009785-A1 | ABSORBABLE ADHESIVE COMPOSITIONS | CLOSURE MEDICAL CORPORATION (US) | 2002-02-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020037310-A1 | Absorbable adhesive compositions | EPCAM, CDH1, ICAM1 | MEN1 1934/4885KMT2A 1270/4885MAPT 2104/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.